GlaxoSmithKline Pharmaceuticals Announces Board Meeting to Review Q1 Financial Results
GlaxoSmithKline Pharmaceuticals Ltd has scheduled a meeting of its Board of Directors to review the company's performance for the first quarter of the fiscal year. The board meeting is set to take place on Monday, August 3, 2026.The primary agenda item for the meeting includes considering and approving the un-audited financial results for the first quarter that ended on June 30, 2026. This review is intended to ensure proper recording of the company's Q1 performance.GLAXO Stock Price Movement
As of 12:24 PM, GlaxoSmithKline Pharmaceuticals Limited sheds 0.49% in live trading, slipping by ₹12.10 to currently trade at ₹2471. The stock has seen a...